StemCell Therapy

After becoming the Association of Paddle Professional's Overall World Champion of 2017, Fiona Wylde has proven that even people with diabetes can overcome challenges posed by the disease and reach the pinnacle of the fast-growing sport of stand up paddleboarding (SUP). If you have diabetes, SUP is emerging as a great sport that you can enjoy without fear and even excel at it if you have what it takes. However, just like any other physical activity that involves aerobic, sprint, or resistance training, SUP can be risky to your health as a result of varying blood glucose responses, and it is up to you to manage those risks so that you can keep having fun and maintain your performance at the highest levels possible.

Foot problems are common in diabetes patients, and since you need healthy feet for SUP, you must take excellent care of them. Over time, diabetes can cause nerve damage in your feet resulting in tingling, pain, and loss of feeling in some cases. Diabetes may also reduce blood flow to your feet, making it hard for cuts, sores, and infections to heal. In some cases, the infection may lead to gangrene forcing you to have a toe, foot, or part of your leg amputated. Thankfully, there are many measures you can take to avoid these problems, starting with checking your feet regularly for cuts, scratches, blisters, and calluses, especially after a day of SUP. This will help you spot problems early when they're still easy to treat. Keep your feet clean at all times and wear shoes that are comfortable and perfectly fitting. A foot massage from your significant other after a day of SUP can also reduce inflammation and promote circulation.

Photo: Shutterstock

You can prevent both hyperglycemia and hypoglycemia during and after SUP through strategic carbohydrate intake and adjusting your dosage and timing of insulin. If your pumped or injected insulin levels are low when you begin SUP, you may need only 10 to 15 grams of carbs to prevent hypoglycemia. If you're getting on your board within two or three hours of bolus insulin, you may need around 50 grams of carbs per hour of SUP. Consult your doctor to ensure that you're taking the correct amount of carbs based on your unique needs. After a few hours of SUP, the carbohydrate levels in your muscles build back up slowly which makes you more sensitive to insulin, contributing to hypoglycemia up to two days later. To avoid this, make sure you're eating adequate amounts of carbs along with insulin before, during, and after SUP.

In addition to eating carbs to maintain blood sugar levels during exercise, you may need to also lower your basal and bolus insulin doses to decrease your hypoglycemia risk. Consult your doctor about your individual needs before you make such adjustments. In some cases, you may need up to a 20 percent reduction both before and after SUP. If you use an insulin pump, you may need to suspend or reduce basal insulin infusion 60 minutes before SUP to prevent hypoglycemia. Regardless of your regimen changes, be sure to track your blood sugar frequently and make necessary adjustments to stay in your target range.

Fiona Wylde racing in Japan. | Photo courtesy: Kure134 / Starboard

Diabetes may be challenging to live with at times, but it shouldn't prevent you from experiencing the joy and sense of freedom that SUP provides. By being prepared and working with your care team to create an effective diabetes management plan, you can engage in SUP without risking your well-being, whether you're doing it for fun or competitively.

See the original post:
How to Practice Paddleboarding Safely When You Have Diabetes - Supconnect.com

Three charities have joined forces to distribute grants to UK researchers examining the impact of COVID-19 on people with diabetes.

Diabetes UK, JDRF, and Moorfields Eye Charity have pledged a total of 315,000 to projects examining which people with diabetes are more at risk from COVID-19, the specific effects for people with type 1 diabetes, and the effects of treatment disruption caused by the pandemic for diabetes patients with vision problems.

Dr Elizabeth Robertson, director of research at Diabetes UK, said: "By understanding how the virus affects people with diabetes, and who might be more at risk of poor outcomes, we will be better able to provide the care, information, and reassurance they need during this difficult time."

Data from England published in May revealed that around 1 in 4 patients who had died in hospital after being diagnosed with COVID-19 also had diabetes.

It also found that people with type 1 diabetes had a higher risk of dying from COVID-19 than those with type 2, or other types of diabetes.

Diabetes UK and JDRF, the type 1 diabetes charity, have co-funded a study into how the coronavirus pandemic is affecting people with type 1 diabetes.

Prof Kathleen Gillespie and her team at the University of Bristol will work with a research group in Milan which has developed a test that can detect coronavirus antibodies in a small sample of blood.

The test will be offered to around 5000 people already participating in ongoing studies of type 1 diabetes, allowing Prof Gillespie to estimate how many people with the condition have contracted COVID-19.

Participants will also be asked to share their experiences of COVID-19 and lockdown including whether they have been shielding, if they have had any COVID-19 symptoms, and how their blood glucose levels have reacted.

Prof Gillespie said: "Although we know that people with type 1 diabetes are at greater risk if they develop COVID-19, we know very little about how this translates to people's experiences of the pandemic.

"With this research, we hope to get a much clearer idea of how the type 1 diabetes community has been affected by coronavirus, and how they can be kept safe and well in future."

John Dennis from the University of Exeter was awarded a share of the funding for a research project aimed at understanding which people with diabetes have a greater risk of poor outcomes from COVID-19.

The independent research fellow in medical statistics will combine and study large health databases to look in detail at different characteristics of people with diabetes, such as their age, and blood sugar levels.

"I think 25% of people in hospital with COVID-19 have diabetes, which is more than you'd expect, based on the standard demographics of people admitted to hospital," he told Medscape News UK.

The ultimate aim of the research was to "provide tools for clinicians to be able to risk stratify people with diabetes after they've been admitted to hospital".

Dr Dennis said the findings could be invaluable to the NHS "in the context of a potential second wave over winter when hospital beds might be at a premium".

He said the 65,000 award was welcome, particularly in the light of fund raising difficulties seen by medical and health charities caused by the pandemic.

Funds were also awarded to the University of Glasgow for a study into the effects of COVID-19 on risk factors for diabetes complications, including blood sugar levels, blood pressure, and bodyweight.

A team led by Naveed Sattar, professor of metabolic medicine, will use health records to look at the impact of the pandemic on these risk factors and rates of diabetes complications over the next 2 years.

They also aim to identify which factors, such as age or ethnicity, put people at higher risk of complications, to help reduce inequalities in treatment.

Diabetes UK and Moorfields Eye Charity have jointly funded a project looking at the impact as a result of the pandemic of deferred treatment on diabetic macular oedema (DMO).

Dr Ranjan Rajendram and colleagues will study individuals with DMO who were scheduled to have anti-vascular endothelial growth factor therapy (antiVEGF) at Moorfields Eye Hospital but who had their treatment deferred due to the pandemic.

The study aims to improve the care given to people with diabetes during the current, and any future, lockdown, and potentially prevent sight loss.

Dr Robertson said: "With DMO being one of the leading causes of loss of vision in people with diabetes, it is key that we understand what impact the COVID-19 pandemic has had on the eye health of people with this condition as missed checks and treatments can have devastating consequences."

Read more:
Funding Boost for Research Into Diabetes and COVID-19 - Medscape

Type 2 diabetes is a condition which causes too much sugar in the blood. It can have devastating consequences if not managed correctly. Following a particular diet has been strongly recommended to help keep blood sugar healthy. What is it?

When it comes to managing your type 2 diabetes, a healthy diet is essential.

There are things a person can eat and drink which have a low Glycaemic Index and are known to help keep blood sugar levels healthy.

This means these foods wont raise the blood sugar and may help one avoid a blood sugar spike.

When it comes to following one of the best diets for type 2 diabetes, leading health experts recommend a low-GI diet.

READ MORE:Type 2 diabetes symptoms: Does your breath smell like this? Expert reveals warning sign

What is the glycaemic index in foods?

The glycaemic index (GI) indicates whether a food type raises blood glucose levels quickly, moderately or slowly.

This means it can be useful for a person living with diabetes.

Certain carbohydrates are digested and absorbed at different rates, and GI is the ranking of how quickly each carbohydrate-based food or drink impacts the blood glucose levels.

The GI index runs from 0 to 100 and usually uses pure glucose, which has a GI of around 100, as the reference.

Slowly absorbed carbohydrates have a low GI rating and foods included in this are fruits and vegetables, unsweetened milk, nuts, pulses, and some wholegrain cereals and bread.

DON'T MISSType 2 diabetes: The best drink to consume to help lower blood sugar[TIPS]Best supplements for high blood pressure: Supplement to lower pressure and reduce risk[TIPS]How to live longer: The hot drink proven to reduce risk of early death from all causes[TIPS]

In a study with the US National Library of Medicine National Institutes of Health, a low-glycaemic index diet was investigated in how it could help with diabetes.

The study noted: We performed a meta-analysis of randomized controlled trials to determine whether low-GI diets, compared with conventional or high-GI diets, improved overall glycaemic control in individuals with diabetes.

The study concluded that choosing low-GI foods in place of conventional or high-GI foods has a small but clinically useful effect on medium-term glycaemic control in patients with diabetes.

The incremental benefit is similar to that offered by pharmacological agents that also target postprandial hyperglycaemia.

In another study with the US National Library of Medicine National Institutes of Health, glycaemic index in the diet of European outpatients with diabetes was analysed.

The study said: The relation of the GI to serum cholesterol (total, LDL, and HDL), and fasting triacylglycerol was analysed in 2810 people with type 1 diabetes.

It concluded that the study in European patients with type 1 diabetes showed that a lower dietary GI is related to lower Hb A(1c) concentrations, independently of fibre intake.

The consumption of bread and pasta had the biggest effect on the overall dietary GI of European outpatients.

When it comes to foods which have a low GI rating and help keep blood sugar low, avocados are one of the best.

Medical News Today said: Polyunsaturated fatty acids and monounsaturated fatty acids are important components of a healthy blood sugar eating plan and avocados could help improve insulin sensitivity.

Other foods include tuna and fish, sour cherries, leafy green vegetables, blueberries, almonds, whole grains and eggs.

Foods with a high GI and best avoided if living with type 2 diabetes include sugar and sugary foods, white bread, white rice and potatoes.

See the original post here:
Type 2 diabetes: The best diet to follow to help lower your blood sugar - Express

Sugary drinks risks, bakery and confectionary items are sources of hidden sugar

White refined sugar is nothing but empty calories. Health experts and nutritionist recommend avoiding sugary foods for good health and weight loss. Eating too much sugar has been linked to increased risk of diabetes and obesity. According to the American Heart Association, men should not consume more than 9 tsp of sugar in a day. This means 36 gms of 150 calories of added sugar in a day. The number is lower for women. 6 tsp or 25 gms or 100 calories per day from sugar is allowed for women, as per AHA.

To see in contrast, one 12-ounce of soda can contains 8 tsp or 32 gms of added sugar. Imagine, one day's sugar allotment gone in drinking that one can!

Sugary drinks and desserts are biggest culprits when it comes to added sugar in your diet. Other sources of hidden sugar come from juices, processed and packaged food, biscuits, bakery and confectionary foods.

In order to regulate your intake of sugar, it is important that you avoid these foods. Also, there are a few healthy alternatives of sugar that you can add to teas, coffee and even homemade sweets to make them healthier.

Also read:6 Surprising Health Benefits Of Dates Apart From Being A Healthy Sugar Substitute

1. Honey: Honey is a delicious, healthier alternative to white refined sugar. Though it is high in calories, it has a lower glycaemic index (GI) value than sugar. It does not raise blood sugar levels as quickly. Keep a close eye on the portion sizes.

2. Date sugar: Dates are supremely nutritious and offer multiple health benefits. They can satisfy the urge of something sweet, while also providing you with added nutrition, which is not the case with sugary foods. Dates do contain natural sugar. On an average, a medium-sized date contains 6 gm sugar. But, it is also packed with fibre. This fibre slows down the release of sugar in blood stream, preventing any spikes in blood sugar levels.

Dates are considered to be a healthy sugar alternativePhoto Credit: iStock

Also read:Say No To Sugary Drinks: Know The Several Risks Associated

3. Coconut sugar: Coconut sugar is extracted from the sap of coconut palm. It contains nutrients like iron, zinc, calcium, potassium and antioxidants. Its GI is lower than sugar and contains insulin. Insulin is a kind of soluble fibre which can slow down digestion, increase feeling of fullness and provide gut-friendly bacteria.

4. Maple syrup: Maple syrup is obtained by cooking down the sap of maple trees. It contains minerals like potassium, calcium, iron, zinc and manganese. Maple syrup is also known to have more antioxidants than honey. Its GI is lower than sugar. Portion size needs to be checked though.

The idea is to control consumption of sugar to prevent weight gain, obesity and diabetes risk. Avoid sources of added sugar mentioned above and you're good to go.

Also read:Sugar: What Happens When You Leave It Entirely? Benefits Of Quitting Sugar Decoded

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

The rest is here:
4 Sugar Substitutes That Can Help In Keeping Diabetes And Obesity Away - NDTV

I'm half way through my 12 months as 2020 Australian of the Year.

I wake up every day knowing over 250 Australians will develop type 2 diabetes that day.

To put the full scale of the type 2 diabetes crisis in perspective, in the first three months of the terrifying COVID-19 crisis, we tragically lost just over 100 Australian lives to this microscopic killer.

During the same period, we lost more than 5000 lives to type 2 diabetes, unnecessarily.

Type 2 diabetes is a preventable dietary disease. People don't need to die - they don't even need to develop type 2 diabetes.

Why are we seeing this tragedy unfold? And why is nothing been done about it?

A flawed dietary guideline, which we have obediently and blindly followed for 40 years, is literally killing us.

Dietary advice we've been fed for decades is wrong

https://nnimgt-a.akamaihd.net/transform/v1/crop/frm/R7sDaMurkWxVpij7Babdbr/19dc1a9e-ea69-4ad6-b58e-4c542e235756.jpg/r11_240_4489_2770_w1200_h678_fmax.jpg

Why the Australian Dietary Guidelines are flawed

news, opinion, National Diabetes Week, Dr James Muecke, Australian of the Year, Type 2 diabetes

2020-07-10T09:00:00+08:00

https://players.brightcove.net/3879528182001/default_default/index.html?videoId=6170406531001

https://players.brightcove.net/3879528182001/default_default/index.html?videoId=6170406531001

Eye surgeon Dr James Muecke on the Five A's that make sugar toxic

We've been encouraged to eat less fat and consume more carbs and yet we've never been fatter, our teeth never more rotten, and type 2 diabetes and its complications never more prevalent.

The scourge of our modern diet has been devastating to Aboriginal people and we're now seeing the disease in children as young as seven.

For two million years, humans evolved on a diverse diet of fresh seasonal foods, and we didn't develop type 2 diabetes.

One hundred years ago, the first dietary guidelines were introduced. At the same time, we saw the introduction of sugary drinks and highly processed foods, the consumption of meat was proclaimed the root of all evil, and - bingo - our health started to plummet.

A multitude of businesses and entire industries have been built on the demonisation of foods sourced from animals.

When the Australian Dietary Guidelines were revised in 2013, a decision was made to not change the recommendations related to dietary saturated fats, despite evidence to the contrary.

Do we really need a guideline to tell us how to eat when its only made us sicker?

It's high time for the Australian Dietary Guidelines to be revised, or removed. I want Australians to be aware the dietary advice we've been fed for decades is wrong.

I want Australians to be aware our dietary guidelines are flawed and the authors conflicted by industry.

The Beverage Council of Australia's deal with the government to reduce the amount of sugar in sugary drinks by 2025 "isn't on track", Dr Muecke writes.

I want Australians to be aware they can eat eggs, full fat dairy and red meat without fearing for their lives or eternal damnation.

The other key factor to our deteriorating health is a lack of accountability, at several critical levels.

At the business level, I've met with major chain stores to bring their attention to the type 2 diabetes crisis and the simple actions they can take to help save lives. Yet there are no plans to remove sugary products from checkouts, where they're preying on our addiction.

At the industry level, I've met with the Beverage Council of Australia. Their deal with the government to reduce the amount of sugar in sugary drinks by 2025 isn't on track and involves broadening the portfolio rather than reducing the amount of sugar in the most highly consumed drinks.

That leaves one last level, the government level. My one last hope.

Government needs to step in to protect the health of all Australians and protect the taxpayers who are funding the type 2 diabetes bill to the tune of $20 billion every year.

In some areas of Australia, over half the adult population has type 2 diabetes or pre-diabetes - a disease almost unheard of in the 1960s and that's now making us more susceptible to pandemics.

My strategy was always a multi-pronged approach. There's no doubt a sugar tax would have a powerful impact and the cost saving to the poorest in our society will far outweigh any perceived injustice.

If the stores using predatory marketing tactics aren't willing to do the right thing, if television continues to advertise to our kids, and if the health star rating system is only being used by 30 per cent of manufacturers, then surely it's time for our government to step in?

It's about being brave. Raising awareness and being accountable are pillars to look up to, not to be admonished. If protecting our kids and the vulnerable is about nannying, then so be it.

In some parts of Australia, over half the adult population has type 2 diabetes or pre-diabetes - a disease that's now making us more susceptible to pandemics.

As a doctor, I'd rather see government put the health of its people above vested interests.

I'm often asked, "What would a good year as Australian of the Year look like?"

I'd be delighted to see a campaign warning Australians of the multitude of health dangers of sugar and an overhaul of our flawed dietary advice mechanism.

Over 20,000 Australians are dying every year due to a preventable disease. A year in which we started saving lives would be a good year for us all.

You can help find the 2021 Australian of the Year, Senior Australian of the Year (65 years+), Young Australian of the Year (16-30 years) and Australia's Local Hero by nominating a champion in your community.

The awards are nominated by the public, so visit australianoftheyear.org.au to nominate someone you admire who is helping to make Australia better.

Nominations are open until July 31.

The story Dietary advice we've been fed for decades is wrong first appeared on The Canberra Times.

Go here to read the rest:
Every day 250 Australians develop type 2 diabetes - a disease that makes us more susceptible to pandemics - Farm Weekly

The Global Diabetes Care Devices Market is segmented on the lines of its glucose monitoring devices, insulin delivery device, type and regional. Based on glucose monitoring device segmentation it covers blood glucose meters, blood glucose test strips, lancing devices, continuous glucose monitoring devices, HbA1c testing kits. Based on insulin delivery device segmentation it covers insulin pumps, insulin syringes and insulin pens. Based on type segmentation it covers therapy type, inject able, oral drugs.TheGlobal Diabetes Care Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

FYI, You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

The Global Diabetes Care Devices Market is expected to exceed more than US$ 33.50 Billion by 2024 at a CAGR of 6% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/diabetes-care-devices-market

The rising predominance of diabetes attributable to stationary ways of life is the prime component for the development of the diabetes devices market. Also, the consistently expanding subsidizing taken after by the heightened innovative work endeavors that are gone for upgrading treatment answers for the control of diabetes is driving the worldwide market towards quick development. Diabetes mellitus is a group of metabolic disorder characterized by high blood sugar levels or high blood glucose level. The innovative advances have already been made and opportunities for product innovation are likely to consist of incremental improvements in performance. The segment related to the growing acceptance of continuous blood glucose monitoring systems by healthcare professionals to monitor real-time blood glucose levels for better management of diabetes.

The scope of the report includes a detailed study of global and regional markets on Global Diabetes Care Devices Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Dexcom Inc., Johnson & Johnson, Merck & Co., Becton, Dickinson and Company, Roche Diagnostics Ltd., Bayer AG, Acon Laboratories, Inc., Ypsomed AG, Novo Nordisk A/S, Medtronic plc, ARKRAY Inc, Terumo Corporation, Dexcom, Inc., and Sanofi. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Diabetes Care Devices Market has been segmented as below:

The Global Diabetes Care Devices Market is Segmented on the lines of Type Analysis, Glucose Monitoring Devices Analysis, Insulin Delivery Devices Analysis and Regional Analysis. By Type Analysis this market is segmented on the basis of Therapy Type, Injectable and Oral Drugs. By Glucose Monitoring Devices Analysis this market is segmented on the basis of Blood Glucose Meters, Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices and HbA1c Testing Kits.

By Insulin Delivery Devices Analysis this market is segmented on the basis of Insulin Pumps, Insulin Syringes and Insulin Pens. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Diabetes Care Devices Market and related technologies.2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.3) Identifications of new market opportunities and targeted promotional plans for Global Diabetes Care Devices Market.4) Discussion of research and development, and the demand for new products and new applications.5) Comprehensive company profiles of major players in the industry.

The restraining factors of Global Diabetes Care Devices Market are as follows:

The major driving factors of Global Diabetes Care Devices Market are as follows:

Request Sample Report from here: https://www.marketresearchengine.com/diabetes-care-devices-market

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Industry Insights

6 Brazil: Diabetes Care Devices Market

7 Russia: Diabetes Care Devices Market

8 India: Diabetes Care Devices Market

9 China: Diabetes Care Devices Market

10 Competitive Landscape

11 Company Profiles

11.1 Roche Diagnostics Limited

11.2 Johnson & Johnson

11.3 Abbott Laboratories

11.4 Bayer AG

11.5 Medtronic PLC

11.6 Becton, Dickinson and Company

11.7 Ypsomed AG

11.8 Novo Nordisk A/S

11.9 Arkray, Inc.

11.10 Sanofi

11.11 Acon Laboratories, Inc.

11.12 Terumo Corporation

11.13 Dexcom, Inc.

Other Related Market Research Reports:

Diagnostic Catheter Market Survive to Reach US$ 4.50 Billion by 2024

Dermatology Devices Market is Determined to Grow US$ 5.0 Billion by 2026

Dental Implants Market is Determined to Grow US$ 6.50 Billion by 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [emailprotected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

See the rest here:
Diabetes Care Devices Market 2019 Trends, Market Share, Industry Size, Opportunities, Analysis and Forecast To 2024 - Owned

Diabetes can affect many parts of your body, including your skin. When diabetes affects the skin, its often a sign that your blood sugar (glucose) levels are too high. This could mean that:

You have undiagnosed diabetes, or pre-diabetes

Your treatment for diabetes needs to be adjusted

If you notice any of the following warning signs on your skin, its time to talk with your doctor.

This skin condition often begins as small raised solid bumps that look like pimples. As it progresses, these bumps turn into patches of swollen and hard skin. The patches can be yellow, reddish, or brown.

You may also notice:The surrounding skin has a shiny porcelain-like appearance

A dark patch (or band) of velvety skin on the back of your neck, armpit, groin, or elsewhere could mean that you have too much insulin in your blood. This is often a sign of prediabetes.The medical name for this skin condition is acanthosis nigricans.

Often causing darker skin in the creases of the neck, AN may be the first sign that someone has diabetes.

When this develops on the fingers, toes, or both, the medical name for this condition is digital sclerosis.

On the hands, youll notice tight, waxy skin on the backs of your hands. The fingers can become stiff and difficult to move. If diabetes has been poorly controlled for years, it can feel like you have pebbles in your fingertips.

Hard, thick, and swollen-looking skin can spread, appearing on the forearms and upper arms. It can also develop on the upper back, shoulders, and neck. Sometimes, the thickening skin spreads to the face, shoulders, and chest.

In rare cases, the skin over the knees, ankles, or elbows also thickens, making it difficult to straighten your leg, point your foot, or bend your arm. Wherever it appears, the thickened skin often has the texture of an orange peel.

This skin problem usually develops in people who have complications due to diabetes or diabetes that is difficult to treat.

Its rare, but people with diabetes can see blisters suddenly appear on their skin. You may see a large blister, a group of blisters, or both. The blisters tend to form on the hands, feet, legs, or forearms and look like the blisters that appear after a serious burn. Unlike the blisters that develop after a burn, these blisters are not painful.

Large blisters like this one can form on the skin of people who have diabetes.

The medical name for this condition is bullosis diabetricorum. Sometimes, its called diabetic bullae.

People who have diabetes tend to get skin infections. If you have a skin infection, youll notice one or more of the following:Hot, swollen skin that is painful

Has it been a year or longer since your last period, and do you get several yeast infections each year? Its possible that you have diabetes or pre-diabetes.

Having high blood sugar (glucose) for a long time can lead to poor circulation and nerve damage. You may have developed these if youve had uncontrolled (or poorly controlled) diabetes for a long time.

Poor circulation and nerve damage can make it hard for your body to heal wounds. This is especially true on the feet. These open wounds are called diabetic ulcers.

If you have diabetes, you should check your feet every day for sores and open wounds.

This skin condition causes spots (and sometimes lines) that create a barely noticeable depression in the skin. Its common in people who have diabetes. The medical name is diabetic dermopathy. It usually forms on the shins. In rare cases, youll see it on the arms, thighs, trunk, or other areas of the body.

Diabetic dermopathy: This 55-year-old man has had diabetes for many years.

The spots are often brown and cause no symptoms. For these reasons, many people mistake them for age spots. Unlike age spots, these spots and lines usually start to fade after 18 to 24 months. Diabetic dermopathy can also stay on the skin indefinitely.

When these bumps appear, they often look like pimples. Unlike pimples, they soon develop a yellowish color. Youll usually find these bumps on the buttocks, thighs, crooks of the elbows, or backs of the knees. They can form anywhere though.

These bumps appear suddenly and clear promptly when diabetes is well-controlled.

When these bumps appear, they often look like pimples. Unlike pimples, they soon develop a yellowish color. Youll usually find these bumps on the buttocks, thighs, crooks of the elbows, or backs of the knees. They can form anywhere though. No matter where they form, they are usually tender and itchy. The medical name for this skin condition is eruptive xanthomatosis.

Whether this skin condition is associated with diabetes is controversial. We know that most people who have granuloma annulare do not have diabetes. Several studies, however, have found this skin condition in patients who have diabetes. One such study found that people with diabetes were most likely to have granuloma annulare over large areas of skin and that the bumps came and went. Another study concluded that people who have granuloma annulare that comes and goes should be tested for diabetes.

This skin condition causes bumps and patches that may be skin-colored, red, pink, or bluish purple.

If you have diabetes, youre more likely to have dry skin. High blood sugar (glucose) can cause this. If you have a skin infection or poor circulation, these could also contribute to dry, itchy skin.

These develop when you have high fat levels in your blood. It can also be a sign that your diabetes is poorly controlled.The medical name for this condition is xanthelasma.

Many people have skin tagsskin growths that hang from a stalk. While harmless, having numerous skin tags may be a sign that you have too much insulin in your blood or type 2 diabetes.

These growths are most common on the eyelids, neck, armpit, and groin.

Diabetes can cause many other skin problems. Most skin problems are harmless, but even a minor one can become serious in people who have diabetes. A board-certified dermatologist can recognize skin problems due to diabetes and help you manage them.

ImagesImage 1: Image Courtesy of Clark C. Otley, MD. All Rights Reserved

Images 3, 7, 8, 9: Used with permission of the American Academy of Dermatology National Library of Dermatologic Teaching Slides.

Image 2 from DermNetNZ

Some images used with permission of Journal of the American Academy of Dermatology

Images 5, 6 and 10: Getty Images

ReferencesCohen Sabban, EN. Cutaneous manifestations of diabetes mellitus from A to Z. Focus session presented at: 74th Annual Meeting of the American Academy of Dermatology; March 4-8, 2016; Washington D.C.

Duff M, Demidova O, et al. Cutaneous manifestations of diabetes mellitus. Clinical Diabetes. 2015;33:40-8.

Kalus AA, Chien AJ, et al. Diabetes mellitus and other endocrine disorders. In: Wolff K, Goldsmith LA, et al. Fitzpatricks Dermatology in General Medicine (seventh edition). McGraw Hill Medical, New York, 2008:1461-70.

McKinley-Grant L, Warnick M, et al. Cutaneous manifestations of systemic disease. In: Kelly AP and Taylor S. Dermatology for Skin of Color. (first edition). The McGraw-Hill Companies, Inc. China, 2009:481-4.

Morgan AJ and Schwartz RA. Diabetic dermopathy: A subtle sign with grave implications. J Am Acad Dermatol. 2008;58:447-51.

Yosipovitch G, Loh KC, et al. Medical pearl: Scleroderma-like skin changes in patients with diabetes mellitus. J Am Acad Dermatol. 2003;48:109-11.

Here is the original post:
Diabetes: 12 warning signs that appear on your skin

Doctor making blood sugar test in clinic. Blood sugar measurement in a medical clinic

Its enough that SARS-CoV-2, the virus that causes Covid-19, can cause pneumonia, kidney failure, blood clots, arrhythmias and even heart attacks, but the potential that the virus may also lead to onset of diabetes provides a new set of implications and potential complications for survivors.

A recent report in Nature details the rationale and proposed mechanisms behind the ability of the virus to damage specialized cells in the pancreas that make insulin, otherwise known as beta cells, contained in surrounding specialized cells (islets).

When beta cells are destroyed, and the body is unable to manufacture insulin, a person develops elevated blood sugar, known as hyperglycemia, which effectively switches the body to an alternate pathway for energy using ketones and ketone bodies as a primary source. Using ketones bodies for energy will trigger a dangerous state where the body produces harmful acids, leading to diabetic ketoacidosis (DKA), which can be fatal if left untreated.

Whats clear is that diabetes is already recognized as a key risk factor for developing severe Covid-19, and persons with this condition have a higher risk of death.

But new research is emerging that the virus not only causes a more severe course in diabetics, but may also trigger onset of the condition in a subset of patients. The potential for a crush of patients with new onset diabetes (Type 1) may be a new reality that the medical community is yet to face.

Clinicians are now seeing previously well people with no history of diabetes who have suddenly developed new onset diabetes after being infected with SARS-CoV-2, along with the dangerous complication, DKA, in which people develop acid in their blood stream, accompanied by rapid breathing, which can lead to shock and death.

If we look back at patients who developed SARS back in 2002-2003, there is a linkage with development of autoimmune conditions such as type 1 diabetes. We also know that many organs which play a role in regulation of blood sugarthe liver, pancreas, kidneys, small intestine and adipose tissue (fat) have a large number of ACE-2 receptors, the receptor on the surface of cells that the virus attaches to using its spike protein. Thats said, the basis for onset of ketosis-prone diabetes following infection with influenza or herpes has been previously reported in the medical literature.

Additional research recently published using miniature lab grown pancreases also suggests that the virus may cause diabetes by injuring the specialized cells, beta cells, that regulate blood sugar.

That said, other researchers have been less convinced about the strength of the connection between Covid-19 and new onset or worsening of diabetes.

We need to keep an eye on diabetes rates in those with prior COVID-19, and determine if rates go up over and above expected levels, said Naveed Sattar, a metabolic-disease researcher at the University of Glasgow, UK in the Nature report.

Clearly, more rigorous studies will be necessary to more definitively establish this link.

That said, a new collaborative research endeavor, the CovDiab Registry, was recently established by a group of researchers to study the presentation and spectrum of illness of patients with newly developed diabetes or complications related to existing diabetes.

The Registry will be useful, the researchers believe, in order to determine not only causes, but whether the diabetic state as a result of Covid-19 is permanent. Another goal will also be to look at those who are pre-diabetic and determine whether Covid-19 accelerates the pathway to Type 2 DM.

In fact, a letter published last month in theNew England Journal of Medicineand signed by an international group of 17 leading diabetes experts involved in the CoviDiab Registry project, announced the establishment of the Global Registry of new cases of diabetes in patients with COVID-19.

Clinical observations thus far demonstrate a bi-directional relationship between Covid-19 and diabetes. On the one hand, diabetes is associated with increased risk of Covid-19 severity and mortality. Between 20 and 30% of patients who died with Covid-19 have been reported to have diabetes. At the same time, new-onset diabetes and life threatening metabolic complications of pre-existing diabetes such as DKA have also been in people with Covid-19.

"Diabetes is one of the most prevalent chronic diseases and we are now realizing the consequences of the inevitable clash between two pandemics, said Francesco Rubino, Professor of Metabolic Surgery at King's College London and co-lead investigator of the CoviDiab Registry project in a press release. Given the short period of human contact with this new coronavirus, the exact mechanism by which the virus influences glucose metabolism is still unclear and we don't know whether the acute manifestation of diabetes in these patients represent classic type 1, type 2 or possibly a new form of diabetes."

One research group at Weill Cornell Medicine in New York City believes that the virus may directly damage the pancreas itself. Using so called organoids, miniature artificial lab- grownorgans, Shuibing Chen and her team demonstrated that the virus can infect beta cells (which make insulin) a portion of which die. The virus seems to also induce production of cytokines which can trigger whats believed to be an inflammatory response that can lead to death of beta cells.

We certainly dont have all the answers just yet. While the organoid study does add some strength to the premise that SARS-CoV-2 may either cause or make existing diabetes worse, this research is still not enough to establish a definitive link, let alone causation.

Its certainly possible that SARS-CoV-2 could produce a heightened inflammatory state which could inhibit the ability of the pancreas to accurately detect glucose and release insulin, while diminishing the capacity and ability of the liver to sense insulin. The end result could potentially lead to diabetes. That said, severe fatigue and muscle atrophy or breakdown could place people at risk for pre-diabetes into a diabetic state.

Long term studies will be essential to better understand the multiple potential mechanisms involved. Stay tuned!

Full coverage and live updates on the Coronavirus

The rest is here:
Can Covid-19 Trigger The Onset Of Diabetes? - Forbes

Study after study has shown that excessive consumption of highly processed carbs and sugar can put a person at risk of developing type 2 diabetes. The trick is finding satisfying substitutes for that soda and white bread. We suggest the following.

Replacing Sugar In Your Diet

A discussion regardingweight loss or a healthier body normally prompts a discussion on how to reduce sugar consumption.Even eatingfruits and vegetables has prompted healthy exchanges among experts.

As such, here are reasonsto cut back on sugar, and substitutes for it:

Replace sugar with natural sources

Despite the controversy over whether natural sugar is any less harmful than the processed kind, the least complicatedway to cut back on sugar is byreplacing it with a natural alternative. Jaggery, for example, can be added to both tea and coffee.

Opt for detox water over sodas

A 2010 Diabetes Care study found that those who drank sugar-laden drinks, 1 to 2 servings a day, had a 26 percent greater chance of developing diabetes than those who drank one serving or less a month. Drink detox water instead, which is made by infusing water with crushed fruits and vegetables for some added flavor.

Bag the can

Canned fruits usually contain syrup, which also has sugar. Instead, buy fresh fruitsfor a healthier alternative.

Hide the sugar bowl

Dont want sugar? Then remove it from the dining table. Out of sight, out of ....

Munch on whole foods

A 2007 Archives of Internal Medicine study conducted among Chinese women found that those who ate foods containing highly processed carbohydrates had a 21 percent greater chance of developing type 2 diabetes than those in the group who ate whole foods.Additionally, theyalso keep you feeling satedfor longer, helping you avoid munching on those snacks sitting on top of your trefrigerator.

Both white and brown sugar came from either the sugarcane or sugar beet plant but they have different properties. Pixabay

Visit link:
Carbs, Sugar and Threat of Diabetes: Reduce Consumption, Reduce Type 2 Risk - Medical Daily

Hyperglycemia occurs when a person with diabetes has too much sugar in their bloodstream. The underlying cause of hyperglycemia is due to a loss of insulin producing cells in the pancreas or when the body develops resistance to insulin. The condition can become dangerous when blood glucose levels stay high for extended periods of time which could lead to the development of long-term complications. Eating the right kinds of food to help stabilise blood sugar levels is well known but what about certain drinks.

Diabetes insipidus is a rare form of diabetes that is not related to blood sugar-related diabetes mellitus but does share some of its signs and symptoms saidDiabetes.co.uk.

The websitecontinued: Diabetes insipidus is simply excessive urination and complications thereof, caused by an antidiuretic hormone called vasopressin.

Diabetes insipidus leads to frequent urination, and this is the most common and clear symptom.

A secondary symptom is increased thirst, as a result of passing so much water and if this is not met, then dehydration can occur which can lead to cracked skin, fatigue, confusion, dizziness and unconsciousness.

There are a variety of factors which contribute to the onset of type 2 diabetes but one of the most common is consuming a large amount of calories throughout the day, especially from added sugars which are found in many foods and, notably, in beverages.

Diabetics are strongly advised to monitor their calorie intake which is often overlooked by the drinks consumed.

Diabetics are recommended to minimise their calories and opting for pure, plain water which contains zero calories is always the best option.

Water does not raise a persons blood sugar levels and studies have shown that when a diabetic has too high a blood glucose level, drinking water enables more glucose to be flushed out of the bloodstream.

Experts agree that water should be the main source of hydration for type 2 diabetes.

If youre consistently dehydrated on a daily basis, you might even be compensating with higher insulin levels than youd need if your body was getting the water it needed, said Diabetes Strong.

The health site added: Its the simple issue of severe dehydration causing the glucose in your bloodstream to become extremely concentrated, and then quickly diluting it with plenty of fluids.

Water actually does far more for our bodies than we realise.

Water aids digestion, lubricates joints, helps flush waste products and performs a host of other important tasks in our body.

See the original post:
Type 2 diabetes: The best drink to consume to help lower blood sugar - Express

Diabetes UKs Chief Executive Chris Askew said a letter signed by more than 12,000 people is calling for the Government to support clinically vulnerable people at work.

The organisation wants more robust protections and safety measures to be put in place to protect those with diabetes and other chronic health conditions.

Last week it was announced that shielding measures were to be eased and the 2 metre social distancing rule was to be reduced to just one.

Diabetes UK said that 64 per cent of the public think the Government should be doing more to protect those at work who have underlying health conditions.

Caroline, from London, has type 2 diabetes and has been constantly worried about her health throughout the pandemic.

The 60-year-old said: I work in a small local supermarket where social distancing just isnt possible and my diabetes is not on the companys list of conditions for people that should be furloughed.

Speak to other people with diabetes:

I tried my best to keep the 2 metre distance, but no one seems to care. Now that it is 1m+ Ive given up entirely. My stress levels have become unmanageable and Ive decided to cut back my hours to try and stay as safe as possible.

I will be losing out financially but if it is between my life or a paycheque I know which one I choose.But some arent so lucky to be able to make that decision and the Government need to consider that.

Mr Askew said: The message from people with diabetes is clear; we want to go about our lives, but were deeply worried about our health as lockdown eases, and we want to know were going to be protected.

Related to this topic:

But what is also clear is that with the next stage of the re-opening of the UK imminent the needs of people with diabetes are not being properly considered. People with long term conditions cannot, and should never have been the Governments blind spot. Lives are at stake.

We reiterate our calls, which we have been doing for weeks, to ensure that people with diabetes are not forgotten, and that additional measures and safeguards are in place and enforced to keep them safe.

In the UK there are 3.9 million people with diagnosed diabetes who were identified as being clinically vulnerable by the Government. From Saturday, July 4, the official advice is those people can meet others outdoors but should be especially careful and be diligent about social distancing and hand hygiene.

Go here to read the rest:
Charity urges Government to step in and protect those with diabetes - Diabetes.co.uk

DUBLIN--(BUSINESS WIRE)--The "Diabetic Retinopathy Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Certain factors that are driving the market growth include the rising prevalence of diabetes and blindness due to the same, growing geriatric population base, increasing technological advancements in diabetic retinopathy surgical instruments.

There is an increasing burden of diabetic retinopathy across the globe. As stated by the International Diabetes Federation (IDF), the global prevalence of DR from 2015 to 2019 was around 27%. The lowest prevalence was in Europe at 20.6% and South East Asia at 12.5% and highest in Africa at 33.8%, Middle East and North Africa 33.8%, and the Western Pacific region at 36.2%.

Hence, the rising prevalence of DR, along with the growing awareness and concern over it, are expected to drive the market growth over the forecast period.

Key Market Trends

Proliferative diabetic retinopathy is Expected to Hold Significant Market Share in the Type Segment

Proliferative diabetic retinopathy (PDR): PDR is the most advanced stage of diabetic retinopathy. At this stage, circulation problems deprive the retina of oxygen. As a result, new, fragile blood vessels can begin to grow in the retina and into the vitreous, the gel-like fluid that fills the back of the eye. The new blood vessels may leak blood into the vitreous, clouding vision.

Symptoms include progressive loss of vision, particularly in those who are not properly followed or treated. The major risk factors for PDR include the duration of diabetes, since 30-34 years of diabetes increase the risk of retinopathy by 65%, according to the reports published by the Columbia University. Hence, the rising prevalence of diabetes is directly contributing to a further increase in the prevalence of PDR.

North America Dominates the Market and Expected to do Same in the Forecast Period

Over the past decade, the prevalence of diabetes in North America has increased. People with diabetes are at risk for diabetic retinopathy. Diabetic retinopathy is the leading cause of new cases of blindness among adults aged 20 to 74 years in the United States. More than 100 million U.S. adults are now living with diabetes or prediabetes, according to a new report published by the Centers for Disease Control and Prevention (CDC). Hence with the increasing number of people living with diabetes is expected to contribute to market growth across the entire region.

Competitive Landscape

The global Diabetic Retinopathy market is moderately competitive and consists of a few major players. Companies like Alimera Sciences, Allergan plc, BCN Peptides, Genentech, Glycadia Pharmaceuticals, Kowa Group, Novartis AG, Oxurion N.V., Regeneron Pharmaceuticals Inc, among others, which hold the substantial market share in the Diabetic Retinopathy market.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Diabetes and Blindness due to the Same

4.2.2 Growing Geriatric Population Base

4.2.3 Increasing Technological Advancements in Diabetic Retinopathy Surgical Instruments

4.3 Market Restraints

4.3.1 Lack of Skilled Ophthalmologists

4.3.2 Extended Approval Time for Drugs

4.4 Porter's Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 Proliferative Diabetic Retinopathy

5.1.2 Non-proliferative Retinopathy

5.2 By Management Approach

5.2.1 Anti-VEGF Drug

5.2.2 Intraocular Steroid Injection

5.2.3 Laser Surgery

5.2.4 Vitrectomy

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle-East & Africa

5.3.5 South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Alimera Sciences

6.1.2 AbbVie Inc. (Allergan plc)

6.1.3 BCN Peptides

6.1.4 Genentech

6.1.5 Glycadia Pharmaceuticals

6.1.6 Kowa Group

6.1.7 Novartis AG

6.1.8 Regeneron Pharmaceuticals Inc

6.1.9 Oxurion N.V.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/w4r3ha

More:
World Diabetic Retinopathy Market 2020-2025 - Rising Prevalence of DR Along With Growing Awareness and Concerns - ResearchAndMarkets.com - Business...

Most people would be shocked to learn that more than 34 million Americans are living with diabetes. That figure represents more than 10% of the countrys population. Sadly, more than 200,000 children in the United States have diabetes.

Numerous companies are hard at work developing diabetes treatments and tools that relieve the pain of this deadly disease. DexCom (DXCM), Livongo Health (LVGO), and Tandem Diabetes Care (TNDM) are three companies involved in diabetes care that you should keep an eye on as we transition to the second half of 2020.

DexCom(DXCM)

Glucose monitoring systems are helping people with diabetes across the globe. DXCM makes these systems for ambulatory use by diabetics and healthcare providers that treat both diabetic patients and non-diabetic patients. The technology measures the patient blood glucose level continuously by transmitting the information to a smartphone. Nearly 700,000 patients were using DXCM glucose monitoring systems as of the start of 2020.

Now that diabetes impacts more people than ever before, DXCMs blood glucose monitoring technology will prove quite valuable. The economic recession should not impact the demand for DXCMs diabetes products, as these tools can make the difference between life and death.

It will surprise no one that DXCM is one of the top-rated stocks in our momentum-basedPOWR Ratings system. Overall, it is the #1 ranked stock in the #10 ranked industry (Medical Devices & Equipment Stocks).

Livongo Health(LVGO)

Every diabetic patient can benefit from reminders to help them manage their disease. LVGO provides this type of information in a high-tech and reliable manner and that is only one segment of LVGOs product offerings. LVGO also provides various sorts of digital health tools, including a platform that uses technology and data science to help people battling chronic conditions.

As time progresses, more and more businesses will be tapping into LVGOs services. LVGO management forecasts year-over-year growth upwards of 110% or more. As LVGO member enrollment continues to increase, the stock could reach new heights. LVGO is up nearly 300% year-to-date.

LVGO has 4 Aces up its sleeve. By that I mean that all 4 out of 5 scores in our POWR Ratings system is an A for the stock. It is also the #5 ranked stock in theMedical Servicesindustry.

Tandem Diabetes Care(TNDM)

It is not often that you find a company making it through the pandemic and recession without a meaningful hit to its operations. TNDM is one of those companies. TNDM executives issued a press release in mid-March, stating its warehouse and manufacturing facilities would continue operating as usual amidst the pandemic.

TNDM sales were just under $98 million during the first quarter of 2020. This figure represents a near 50% rise on a year-over-year basis. TNDMs insulin pump sales grew by nearly 20% during that same period. The company recently agreed to a deal with Abbott Laboratories to provide patients withenhanced diabetes managementtools.

How does TNDM stack up for the POWR Ratings?

A for Trade Grade

A for Buy & Hold Grade

B for Industry Rank

A for Peer Grade

A for overall POWR Rating

It is also the #10 rated stock in the Medical Services industry.

Want More Great Investing Ideas?

9 BUY THE DIP Growth Stocks for 2020

Is the Bull S#*t Rally FINALLY Over?

7 Safe-Haven Dividend Stocks for Turbulent Times

Top 3 Investing Strategies for 2020

DXCM shares were trading at $429.85 per share on Wednesday afternoon, up $3.99 (+0.94%). Year-to-date, DXCM has gained 96.51%, versus a -1.48% rise in the benchmark S&P 500 index during the same period.

Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...

See the original post:
DXCM: 3 Top Diabetes Stocks for the Second Half of 2020 - StockNews.com

Spectrum Generations in partnership with Healthy Living for ME will be offering a free workshop to help individuals with diabetes, prediabetes, their caregivers or family members. Living Well with Diabetes will be offered beginning Monday, August 13 and running through September 17. Workshops participants will meet weekly from 9:30 - 11:30 a.m.

Topics such as testing your blood sugar, menu planning, stress management, increasing activity level, treating low blood sugar, caring for your feet, and healthy eating will be discussed.

This series is free and open to the public but registration is required. Please call (207) 620-1642 or emailjpaquet@healthylivingforme.orgfor more information and to register. Technical support is available.

Healthy Living for ME is a statewide network of evidence-based programs that empower adults to address and better manage their health issues. All workshops are listed athealthylivingforme.org.

About Spectrum GenerationsSpectrum Generations, the Central Maine Area Agency on Aging and Aging and Disability Resource Center, has been a leading provider of information and advice, referrals, programs and activities for adults for over 30 years. Todays Spectrum Generations is poised to serve adults of all ages and backgrounds in a changing, challenging world. We are here for you as you look forward to longer, more active lives and seek to engage in new physical and intellectual challenges.

About Healthy Living for MEHealthy Living for ME brings together Spectrum Generations, SeniorsPlus, and Aroostook Agency on Aging three of Maines Area Agencies on Aging in a partnership to deliver statewide chronic disease self-management and falls prevention classes. FMI or to find a class, visit:healthylivingforme.orgor on Facebook @HLforME

Read this article:
Free diabetes, nutrition program offered through Zoom - PenBayPilot.com

Diabetes management requires management of blood sugar levels

Diabetes diet should include foods that can help in stabilisingblood sugar levels. Glycemic index is a commonly used tool that helps determine foods that are safe for consumption by diabetics. It is a value that is used to measure how specific food affects blood sugar levels. It helps you understand how fast your body converts the carbs present in the food into glucose. Two foods with the same amount of carbs can have different glycemic index numbers.

Your diet must include lots of vegetables.They are loaded with essential nutrients and fibre that are beneficial for the body. Vegetables with low GI can be a part of a diabetes diet. The lower the GI number, the lesser is the impact on blood sugars. There are three GI ratings- low GI: 55 or less, Medium GI- 56-69 and High GI- 70 or above. Here's a list of vegetables with low GI that diabetes can add to their diet.

Broccoli is a non-starchy vegetable that contains very few carbs. This green vegetable is loaded with essential nutrients that can beneficial for your overall health in several ways. It is alsolow in calories.

Broccoli is loaded with water and fibrePhoto Credit: iStock

Tangy tomatoes are also beneficial for diabetics. These also have a low-GI ranking. Tomatoes are also good for your heart health. You can add tomatoes to different recipes. These can be consumed both raw and cooked.

Also read:Are You Eating Enough Tomatoes? If Not, Then You Must; Here's Why

Beetroot is a popular root vegetable that contains essential vitamins, plant compounds and minerals. It is low in calories and high in vitamin C that can boost your immunity levels too.

Also read:Beetroot Health Benefits: Weight Loss, Controlled Blood Pressure, Better Digestion And Much More; Know All Benefits Beetroot Can Offer

Spinach is one of the healthiest leafy greens. It is beneficial for diabetics as well as for weight loss. You can add spinach to salads, soups, sandwiches and other recipes. Boiled spinach can also be a part of your diet.

A cup of boiled spinach can help in weight lossPhoto Credit: iStock

Carrots have a GI score of 39. Carrots contain protein and fibre. Carrot veggie sticks are a healthy snack you can try to beat hunger pangs in the evening.

Also read:Carrot Juice Health Benefits: Health Coach Luke Coutinho Tells Why You Must Include It In Your Diet

Vegetables are power-packed with nutrients. Diabetics should first consume in moderation. Later, you may consult your doctor to know the exact quantity that suits your diet. Number of carbs also affects the blood sugar levels. GI also has certain limitations as it may vary in cooked and raw form of the same vegetable.

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.

See the original post here:
Diabetes Diet: 5 Low-Glycemic Vegetables Diabetics Must Add To Their Diet - NDTV

Diabetes diet management: Here are 7 foods with high GI that diabetics must avoid to balance blood sugar  |  Photo Credit: iStock Images

New Delhi: Diabetes has already reached epidemic levels around the world. With a rise in chronic diseases such as heart health issues, kidney diseases, and diabetes, it becomes extremely important to take care of what we eat. People who already suffer from diabetes not only need to keep a regular check on their blood sugar, but also need to be very mindful of what they need, not just in terms of how many spoons of sugar they add to their tea or coffee, but also with respect to other properties of food, such as the Glycemic Index.

To determine the intensity of sweetness, and sugar content of foods, a unit called the Glycemic Index has been devised. The Glycemic Index is a relative ranking of carbohydrate in foods according to how they affect their blood sugar levels. GI is one of the most important considerations for diabetics when it comes to managing their diet. These GI values of 5 most common foods consumed by people worldwide, and how they are likely to affect blood sugar levels for diabetics can help diabetes manage their diet better.

Cutting off unnatural sources of sugar like crystalized sugar, syrup, etc from your diet is recommended to stay healthy, keep your weight in check. If you have diabetes, it is recommended to cut off all sources of sugar, especially processed and unnatural sources. However, natural sources of sugar are unlikely to harm your health, but being aware of their sugar content can help you manage your condition better.

Disclaimer: Tips and suggestions mentioned in the article are for general information purposes only and should not be construed as professional medical advice. Always consult your doctor or a professional healthcare provider if you have any specific questions about any medical matter.

See the article here:
Diabetes diet management: Here are 7 foods with high GI that diabetics must avoid to balance blood sugar - Times Now

Add fruit, veggies and grains to diet to reduce type 2 diabetes risk

London, July 9 (IANS) Higher consumption of fruit, vegetables and whole-grain foods are associated with a lower risk of developing type 2 diabetes, say researchers.

The findings, published in the journal The BMJ, suggest that even a modest increase in consumption of these foods as part of a healthy diet could help prevent type 2 diabetes.

In the first study, a team of European researchers examined the association between blood levels of vitamin C and carotenoids (pigments found in colourful fruits and vegetables) with the risk of developing type 2 diabetes.

Vitamin C and carotenoid levels are more reliable indicators of fruit and vegetable intake than using dietary questionnaires.The research team compared 9,754 adults with new-onset type 2 diabetes to a group of 13,662 adults who remained free of diabetes.

The researchers calculate that every 66 grams per day increase in total fruit and vegetable intake was associated with a 25 per cent lower risk of developing type 2 diabetes.

In the second study, the research team used questionnaires to measure the whole grain intake of more than 158,000 women and nearly 37,000 men who were free from diabetes, heart disease and cancer.

After adjusting for lifestyle and dietary risk factors for diabetes, participants in the highest category for total whole grain consumption had a 29 per cent lower rate of type 2 diabetes compared with those in the lowest category.

For individual whole-grain foods, the researchers found that consuming one or more servings a day of whole-grain cold breakfast cereal or dark bread was associated with a lower risk of type 2 diabetes compared with consuming less than one serving a month.

The findings showed that eating two or more servings a week of oatmeal was associated with a 21 per cent lower risk of diabetes, a 15 per cent lower risk for added bran and a 12 per cent lower risk for brown rice and wheat germ, when compared to eating less than one serving a month.

And for fruit and vegetables, the findings also suggest that consumption of even a moderately increased amount among populations who typically consume low levels could help to prevent type 2 diabetes.

--IANS

bu/arm

See the original post:
Add fruit, veggies and grains to diet to reduce type 2 diabetes risk - Outlook India

According to a new population-based cohort study, over three-quarters of patients with type 2 diabetes (T2D) in England have at least one other physical or mental health condition. The findings were published in the journal BMJ Open .

Researchers compared 108,588 T2D patients with 528,667 individuals without T2D, registered in English general practices. They analysed the annual patterns of several physical and mental health conditions among individuals with and without T2D.

The findings showed that 77%of individuals with T2D had one or more physical or mental health comorbidity. Individuals with T2D had a 2.4-fold, 1.8-fold, 1.6-fold and 1.6-fold higher likelihood of having schizophrenia, depression, asthma and chronic obstructive pulmonary disease (COPD), respectively, compared with individuals without T2D. Individuals with T2D had twice the prevalence of cardiovascular disease than their non-T2D counterparts. Additionally, osteoarthritis, hypothyroidism and anxiety were also more prevalent in individuals with T2D.

The lead author, Dr Salwa Zghebi, said: "We highlight the need for future clinical guidelines in diabetes to refocus patient-centred care on non-cardiometabolic conditions such as asthma, COPD, anxiety, depression, schizophrenia, and osteoarthritis."

"Mental health is of particular concern and our data highlight a profound clinical need in young people with type 2 diabetes who might benefit enormously from mental health interventions," she added.

Zghebi SS, Steinke DT, Rutter MK, Ashcroft DM. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open. 2020;10(7):e033866. doi: 10.1136/bmjopen-2019-033866. PMID: 32611677. Full text.

This article originally appeared on Univadis, part of the Medscape Professional Network.

Read the original:
Three-quarters of Patients with Type 2 Diabetes Have Other Comorbidities - Medscape

(MENAFN - GetNews) According to report published by Grand View Research, Growing awareness over diabetes coupled with preventive measures taken by consumers is anticipated to spur the market growth.

The global diabetic food market size is expected to reach USD 11.76 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for diabetic food in the medical sector is anticipated to fuel the market growth.

Diabetic Food is the diet which is recommended for individuals with high blood glucose or diabetes mellitus. It usually consists of edible products which are rich in refined carbohydrates and have low sugar content. Different individuals living with diabetes are recommended different types of diet based on their condition. In cases of hypoglycemia many are recommended to have a diet which increases their blood glucose level rapidly and in other cases, individuals suffering from diabetes mellitus are recommended to have a diet which reduces their high glycemic index (GI) carbohydrates intake.

Major technological shifts in the manufacturing processes and the use of advanced machinery are anticipated to positively affect the market growth. Many firms are investing in creating android and iPhone applications to help the individuals living with diabetes to better manage their health. These applications include BG Monitor Diabetes, Blue Loop, Calorie Counter PRO, Diabetes in Check and Diabetes Tracker. These applications help people to set reminders, create graphs and spreadsheets of their data, calculate their calorie intake, insulin requirements and track their progress.

The diabetic food industry is governed by various regulations that cover the entire lifecycle ranging from production to end use. Diabetic products used in the healthcare industry need to strictly abide by the stringent U.S. FDA regulations. Health disorders are a result of unhealthy lifestyles such as long working hours, sedentary lifestyle, smoking, poor food habits and alcohol consumption and are anticipated to influence the industry growth over the forecast period.

U.S. diabetic food market revenue by application, 2014 - 2025 (USD Million)

Request a sample Copy of the Diabetic Food Market Research Report @ https://www.grandviewresearch.com/industry-analysis/diabetic-food-market/request/rs1

Key Takeaways Of The Report :

The global diabetic food demand was USD 7 billion in 2015 and is estimated to grow at a CAGR of 5.4% from 2016 to 2025

Demand in dairy application is estimated to exceed USD 3 billion by 2025, owing to its probiotic properties

Baked products application segment is estimated to grow at a CAGR of 5.5% over the forecast period owing to the large demand of sugar-free baked products by health conscious consumers

Product demand in Asia Pacific is expected to grow at a significant rate of 6.0% over the next nine years owing to the emerging economies and the growing investment in the medical foods sector

Diabetic foodmarket in North America is anticipated to exceed USD 4 billion by 2025, owing to the growing medical sector and imbalance in work life and unhealthy lifestyle

Companies such as Coca-Cola Company and PepsiCo Inc. offer raw materials including, dietary syrups, carbon dioxide, sweeteners, and juices, to various industries including, frozen foods, nutritional and functional foods, beverages, medical and processed foods.

Business expansions by companies, such as Mondelz International to establish global research, development & quality (RDQ) network of the future, is anticipated to strengthen the market presence over the coming years

Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/1906/ibb

Global diabetic food market revenue by region, 2015 (USD Million)

Grand View Research has segmented the global diabetic food market on the basis of product, application, and region:

Diabetic Food Market, Application Outlook (Revenue, USD Million, 2014 - 2025)

Diabetic Food Market, Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

Europe

Asia Pacific

CSA

MEA

Grasp advance knowledge on Diabetic Food Market through in-depth Blogs, Research Insights:

Access Blog " https://www.grandviewresearch.com/blog/diabetic-food-market-size-share "

Media Contact Company Name: Grand View Research, Inc. Contact Person: Sherry James, Corporate Sales Specialist - U.S.A. Email: Send Email Phone: 1-415-349-0058, Toll Free: 1-888-202-9519 Address: 201, Spear Street, 1100 City: San Francisco State: California Country: United States Website: https://www.grandviewresearch.com/industry-analysis/diabetic-food-market

Follow this link:
Diabetic Food Market Size Predicted To Reach USD 11.76 Billion By 2025 | Grand View Research Inc. - MENAFN.COM

JDRF, the world's leading type 1 diabetes charity, is partnering with Diabetes UK to find out how the coronavirus pandemic is affecting people with type 1 diabetes.

Whilst risk of death from COVID-19 is low, for people with and without type 1 diabetes, NHS figures nonetheless show the risk is higher for those with the condition.

Scientists dont know how many people with type 1 have had coronavirus and recovered, obscuring the full impact that the virus is having on the UKs 400,000 people with type 1.

Now, JDRF and Diabetes UK will co-fund Professor Kathleen Gillespie, at the University of Bristol, to find out.

Professor Gillespie's team will work with a research group in Milan that has developed a test that can detect coronavirus antibodies in a small sample of blood small enough to be collected via post.

By offering this test to around 5,000 people participating in ongoing studies of type 1 diabetes (the Barts Oxford study and UK TrialNet), Professor Gillespie will be able to estimate how many people contracted coronavirus.

She will also ask participants to share their experiences of COVID-19 and lockdown including whether they have been shielding, if they have had any COVID-19 symptoms, and how their blood glucose levels have reacted.

With this information, Professor Gillespie will be able to see how the type 1 diabetes community has been hit by COVID-19.

This will give scientists and clinicians a clearer idea of the risk that coronavirus poses to people with type 1, enabling healthcare teams to better support and protect people with the condition.

Kathleen Gillespie, Professor of Molecular Medicine at the University of Bristol, said: "Although we know that people with type 1 diabetes are at greater risk if they develop COVID-19, we know very little about how this translates to peoples experiences of the pandemic.

"With this research, we hope to get a much clearer idea of how the type 1 diabetes community has been affected by coronavirus, and how they can be kept safe and well in future."

Rachel Connor, Director of Research Partnerships at JDRF, said: "Everyone with type 1 diabetes is different, and Professor Gillespies work will shed some much-needed light on the individual experiences behind the statistics.

"Were hopeful that with this information, policymakers and healthcare teams will be able to give people with type 1 diabetes the advice and support they need."

Dr Elizabeth Robertson, Director of Research at Diabetes UK, said: "There's never an easy time to live with diabetes, but the COVID-19 pandemic presents particular challenges for people with type 1. It is vital that we understand how having COVID-19, as well as living in lockdown, affects people with type 1 diabetes so that we can provide them with the best advice and care during this difficult time and in the future.

"We're delighted to join forces with JDRF to fund Professor Gillespie's research, which will help us to do this by giving important insights into the experiences of people with type 1 diabetes during the pandemic."

About JDRF

JDRF is the leading global organisation funding type 1 diabetes research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat type 1 diabetes and its complications. To accomplish this, JDRF has invested more than 1 billion since our inception. We collaborate with the most talented minds to develop and deliver a pipeline of innovative therapies to people living with type 1 diabetes. Our staff and volunteers around the globe are dedicated to campaigning for our vision of a world without type 1 diabetes.

For more information, please visit jdrf.org.uk or follow us on Twitter: @JDRFUK.

About type 1 diabetes

About the Bristol UNCOVER group

In response to the COVID-19 crisis, researchers at the University of Bristol formed the Bristol COVID Emergency Research (UNCOVER) Group to pool resources, capacities and research effortsto combat this infection.

BristolUNCOVER includes clinicians, immunologists, virologists, synthetic biologists, aerosol scientists, epidemiologists and mathematical modellers and has links to behavioural and social scientists, ethicists and lawyers and is supported by a large number of junior academic and administrative colleagues.

Follow Bristol UNCOVER on Twitter at:https://twitter.com/BristolUncover

For more information about the University of Bristols coronavirus (COVID-19) research priorities visit:www.bristol.ac.uk/research/impact/coronavirus/research-priorities/

Read more from the original source:
July: Diabetes Kathleen Gillespie | News and features - University of Bristol